The AIDS fight offers a COVID vaccine patent pathway
Updated:
Updated:
May 22, 2021 07:30 IST
There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle
Share Article
AAA
There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle
In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners voluntarily licensing their products to other companies, especially Indian producers who are experienced at mass-producing low-cost medications. This can also be done by temporarily suspending patent rights for COVID vaccines, an option that is being pursued by India and South Africa through the World Trade Organization (WTO) and one that is legal in the event of a public health emergency, accor
HIV Drug IP Waiver Success Should Guide COVID Vax Rollout
law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.
HIV Drug IP Waiver Success Should Guide COVID Vax Rollout
law360.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from law360.com Daily Mail and Mail on Sunday newspapers.